The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Diclo 75mg prolonged release tablets



Pinewood Laboratories LtdPA0281/106/001

Main Information

Trade NameDiclo 75mg prolonged release tablets
Active SubstancesDICLOFENAC SODIUM
Dosage FormProlonged-release tablet
Licence HolderPinewood Laboratories Ltd
Licence NumberPA0281/106/001

Group Information

ATC CodeM01AB Acetic acid derivatives and related substances
M01AB05 diclofenac

Status

License statusAuthorised
Licence Issued27/05/1999
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to market only product authorised in Ireland under product authorisation number PA0711/009/003.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0056-028-024
Interchangeable List DocumentPDF of Interchangeable List
« Back